Semaglutide
The GLP-1 receptor agonist that turned obesity pharmacology into a mainstream conversation. Once-weekly injection, ~7-day half-life, and the largest randomised dataset of anything in this catalogue.
Choose an option
- Pay with Bitcoin
- Discreet shipping within Germany
- Purity-guaranteed batches
- 14-day refund period if unsatisfied
Delivery & guarantee
Orders typically arrive within 3 weeks.
If your delivery arrives late, you'll receive a discount on your next order.
About
Semaglutide mimics glucagon-like peptide-1, a gut hormone that tells the pancreas to release insulin, slows gastric emptying, and signals the hypothalamus to stop being hungry. The STEP and SUSTAIN trial programmes are why every other peptide on this page gets benchmarked against it: 15% body-weight loss at 2.
Read the full research guideWhy people choose it
- Steady appetite reduction that begins within the first two weeks and deepens through titration
- 10 to 15% body-weight loss in obesity trials at the 2.4 mg dose; closer to 6 to 8% at the 1.0 mg diabetes dose
- Meaningful HbA1c drops (1 to 2 percentage points) in type 2 diabetics on top of the weight effect
- A growing literature on reduced cravings beyond food. Alcohol, nicotine, and compulsive behaviours have shown up as secondary findings
At a glance
- Experience level
- Beginner-friendly
- Administration
- Subcutaneous
Sold for laboratory research only. Not for human consumption. No therapeutic claims are made.
Sign in to view this product
Semaglutide
Log in or create a free account to see full details and prices.
Don't have an account? Sign up